Facial paralysis probably related to systemic isotretinoin
DOI:
https://doi.org/10.18203/issn.2454-2156.IntJSciRep20191860Keywords:
Facial paralysis, Isotretinoin, Drug withdrawalAbstract
We report a patient with severe acne who developed facial paralysis after two months of treatment with oral isotretinoin. Drug withdrawal resulted in a complete clinical recovery. Our case and a review of the literature indicate that oral isotretinoin might be capable of causing a dysfunction of predominantly sensory nerve fibers in some individuals. Clinicians should be aware of possible neurological sensorial symptoms during isotretinoin therapy.
Metrics
References
Jindal SR. Isotretinoin with pulsed azithromycin and low dose oral isotretinoin alone in the management of moderate to severe acne. Int J Res Dermatol. 2018; 4(1):58-61.
al-Khawajah MM. Isotretinoin for acne vulgaris. Int J Dermatol. 1996;35(3):212-5.
Onder HI, Turan H, Kilic AC, Kaya M, Tunc M. Premacular hemorrhage due to isotretinoin use. Cutan Ocul Toxicol. 2013;32(2):170-2.
Laroche ML, Macian-Montoro F, Merle L, Vallat JM. Cerebral ischemia probably related to isotretinoin. Ann Pharmacother. 2007;41(6):1073-6.
Chroni E, Pasmatzi E, Monastirli A, Georgiou S, Katsoulas G, Polychronopoulos P, et al. Short-term oral isotretinoin therapy does not cause clinical or subclinical peripheral neuropathy. J Dermatolog Treat 2006;17(1):6-8.
Aydogan K, Karli N. Effects of oral isotretinoin therapy on peripheral nerve functions: a preliminary study. Clin Exp Dermatol. 2007;32(1):81-4.
Charalabopoulos K, Papalimneou V, Charalabopoulos A, Hatzis J. Two new adverse effects of isotretinoin. Br J Dermatol. 2003;148(3):593.
Fiallo P. Severe acute myopathy induced by isotretinoin. Arch Dermatol. 1996;132(12):1521–2.
Chroni E, Sakkis T, Georgiou S, Monastirli A, Pasmatzi E, Paschalis C, et al. Stiff-person syndrome associated with oral isotretinoin treatment. Neuromuscular Dis. 2002;12(9):886–8.
McCaffery P, Drager UC. Regulation of retinol acid signaling in the embryonic nervous system: a master differentiation factor. Cytokine Growth Factor Rev. 2000;11(3):233–49.
Downloads
Published
How to Cite
Issue
Section
